NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

MetLife, Inc. MET | NYSE

$95.31 $0.00 | 0.00%

Next Earnings: Jul 27, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $67.33 - $95.91

10 Year MET Performance Metrics:

Total Return (with DRIP): 245.6% (13.20% CAGR)
Total Return (no DRIP): 196.8% (11.49% CAGR)
Share Price: 147.7% (9.49% CAGR)
Dividend Increase: 66.2% (5.09% CAGR)
Dividend Yield (FWD): 2.49% ($2.37)
MET 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

MET Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
MET Dividend CAGR:1Y: 4.41%2Y: 4.27%5Y: 4.30%10Y: 5.21%
Share Price
MET Price CAGR:1Y: 22.73%2Y: 11.99%5Y: 10.54%10Y: 9.49%

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

MET Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - MET
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - MET
7-Day FREE Trial Get Full Access Now!

MET Earnings, Revenue, Cash & Debt, Shares Outstaning:

MET - Revenue
7-Day FREE Trial Get Full Access Now!
MET Revenue CAGR:1Y: 4.44%2Y: 8.99%5Y: 4.15%10Y: 0.35%
MET - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
MET EPS CAGR:1Y: 35.94%2Y: 25.77%5Y: 34.18%10Y: 3.79%
MET - Net Income
7-Day FREE Trial Get Full Access Now!
MET Net Income CAGR:1Y: 25.40%2Y: 16.91%5Y: 27.05%10Y: -1.18%
MET - EBITDA
7-Day FREE Trial Get Full Access Now!
MET EBITDA CAGR:1Y: 9.93%2Y: 0.00%5Y: 28.09%10Y: -5.83%
MET - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
MET Free Cash Flow CAGR:1Y: -36.95%2Y: 7.43%5Y: 3.73%10Y: 23.87%
MET - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
MET Free Cash Flow / Share CAGR:1Y: -34.02%2Y: 13.15%5Y: 10.28%10Y: 30.53%
MET - Operating Income
7-Day FREE Trial Get Full Access Now!
MET Operating Income CAGR:1Y: 11.30%2Y: 20.55%5Y: 24.00%10Y: -7.35%
MET - Gross Profit
7-Day FREE Trial Get Full Access Now!
MET Gross Profit CAGR:1Y: 50.46%2Y: -33.49%5Y: -14.52%10Y: -9.09%
MET - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
MET Shares Outstanding CAGR:1Y: -4.56%2Y: -5.12%5Y: -5.97%10Y: -5.12%
MET - Share Buybacks
7-Day FREE Trial Get Full Access Now!
MET Share Buybacks CAGR:1Y: -46.49%2Y: -19.74%5Y: -5.45%10Y: 26.85%
MET - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
MET Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MET - Expenses
7-Day FREE Trial Get Full Access Now!
MET Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MET - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
MET - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
MET - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
MET - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
MET - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
MET - Cash & Debt
7-Day FREE Trial Get Full Access Now!
MET - Dividends
7-Day FREE Trial Get Full Access Now!
MET Dividend CAGR:1Y: 4.41%2Y: 4.27%5Y: 4.30%10Y: 5.21%
MET - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
MET Revenue CAGR:1Y: 4.44%2Y: 8.99%5Y: 4.15%10Y: 0.35%
MET - Revenue by Region
7-Day FREE Trial Get Full Access Now!
MET Revenue CAGR:1Y: 4.44%2Y: 8.99%5Y: 4.15%10Y: 0.35%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MET - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
MET Actual Revenue CAGR:1Y: 4.44%2Y: 8.99%5Y: 4.15%10Y: 0.35%
MET - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
MET Actual EPS CAGR:1Y: 35.94%2Y: 25.77%5Y: 34.18%10Y: 3.79%
MET - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
MET Actual Net Income CAGR:1Y: 25.40%2Y: 16.91%5Y: 27.05%10Y: -1.18%
MET - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
MET Actual EBITDA CAGR:1Y: 9.93%2Y: 0.00%5Y: 28.09%10Y: -5.83%

Ratios, Profit Margins & Return on Capital:

MET - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
MET Net Profit Margin CAGR:1Y: 20.12%2Y: 7.24%5Y: 21.98%10Y: -1.54%
MET - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
MET Gross Profit Margin CAGR:1Y: 44.06%2Y: -38.98%5Y: -17.93%10Y: -9.41%
MET - Price to Earnings
7-Day FREE Trial Get Full Access Now!
MET - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
MET - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
MET - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

MET Dividends Info:

Annual Dividend: $2.37
Forward Yield: 2.49%
Ex-Dividend Date: 2026-08-04
Lifetime Dividends / Share: $29.69

MET Dividend History: Dates, Payments & Yield list

Below is a schedule of all MET dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/04/202609/08/2026$0.5932.45%0%$0.00
05/12/202606/09/2026$0.5932.92%2.77%$85.57
02/03/202603/10/2026$0.5682.95%3.22%$70.60
11/04/202512/09/2025$0.5682.83%2.92%$77.82
08/05/202509/09/2025$0.5682.97%2.86%$79.29
05/06/202506/10/2025$0.5682.88%2.86%$79.43
02/04/202503/11/2025$0.5452.58%2.78%$78.45
11/05/202412/16/2024$0.5452.76%2.63%$82.74
08/06/202409/10/2024$0.5453.11%2.92%$74.63
05/06/202406/11/2024$0.5452.96%3.16%$69.06
02/05/202403/14/2024$0.5203.16%2.89%$71.90
11/08/202312/14/2023$0.5203.47%3.11%$66.90
08/07/202309/14/2023$0.5203.18%3.15%$65.93
05/08/202306/14/2023$0.5202.83%3.86%$53.94
02/06/202303/14/2023$0.5001.43%3.39%$59.07
11/07/202212/14/2022$0.5002.68%2.75%$72.84
08/08/202209/14/2022$0.5003.11%3.01%$66.41
05/09/202206/14/2022$0.5002.96%3.23%$61.86
02/07/202203/14/2022$0.4802.79%2.97%$64.69
11/08/202112/14/2021$0.4802.98%3.16%$60.80
08/09/202109/14/2021$0.4803.11%3.16%$60.78
05/10/202106/14/2021$0.4802.8%3.03%$63.31
02/04/202103/15/2021$0.4603.55%3.04%$60.54
11/02/202012/14/2020$0.4604.7%4.01%$45.84
08/03/202009/14/2020$0.4604.83%4.74%$38.84
05/07/202006/12/2020$0.4605.17%4.91%$37.45
02/03/202003/13/2020$0.4403.54%5.51%$31.93
11/04/201912/13/2019$0.4403.66%3.49%$50.38
08/05/201909/13/2019$0.4403.77%3.64%$48.37
05/06/201906/13/2019$0.4403.57%3.63%$48.51
02/04/201903/13/2019$0.4203.72%3.76%$44.70
11/05/201812/13/2018$0.4203.72%4.25%$39.52
08/03/201809/13/2018$0.4203.62%3.69%$45.52
05/04/201806/13/2018$0.4203.41%3.57%$47.00
02/02/201803/13/2018$0.4003.18%3.4%$47.10
11/03/201712/13/2017$0.4002.69%3.03%$52.84
08/03/201709/13/2017$0.3572.99%2.93%$48.65
05/04/201706/13/2017$0.3573.04%3%$47.51
02/02/201703/13/2017$0.3573.11%2.95%$48.27
11/03/201612/13/2016$0.3573.35%2.82%$50.53
08/04/201609/13/2016$0.3573.92%3.64%$39.19
05/05/201606/13/2016$0.3573.56%3.73%$38.24
02/03/201603/14/2016$0.3343.58%3.42%$39.13
11/04/201512/11/2015$0.3342.92%3.18%$42.00
08/05/201509/11/2015$0.3342.61%3.09%$43.25
05/07/201506/12/2015$0.3342.74%2.69%$49.71
02/04/201503/13/2015$0.3122.87%2.73%$45.77
11/05/201412/12/2014$0.3122.43%2.65%$47.08
08/06/201409/12/2014$0.3122.44%2.52%$49.44
05/07/201406/13/2014$0.3122.35%2.57%$48.55
02/04/201403/13/2014$0.2452.3%2.13%$46.11
11/06/201312/13/2013$0.2452.11%2.15%$45.62
08/07/201309/13/2013$0.2452.98%2.25%$43.52
05/07/201306/13/2013$0.2452.94%2.45%$40.03
02/04/201303/13/2013$0.1652.48%1.85%$35.63
11/07/201212/14/2012$0.6602.27%9.3%$28.38
11/07/201112/14/2011$0.6602.19%9.7%$27.21
11/05/201012/14/2010$0.6601.76%6.76%$39.00
11/05/200912/14/2009$0.6604.38%8.01%$32.95
11/06/200812/15/2008$0.6602.3%10.07%$26.19
11/02/200712/14/2007$0.6601.16%4.78%$55.20
11/02/200612/15/2006$0.5261.94%4.02%$52.34
11/03/200512/15/2005$0.4631.04%4.13%$44.88
11/03/200412/13/2004$0.4101.8%4.53%$36.19
11/05/200312/15/2003$0.2051.42%2.77%$29.59
11/06/200212/13/2002$0.1870.79%2.98%$25.10
11/02/200112/14/2001$0.1781.48%2.68%$26.57
11/03/200012/15/2000$0.1780.76%2.29%$31.19

Projected Future Returns & Dividends for MET

Based on past 10-year performance, here are MET growth metrics:

Share price CAGR of +9.49%
Dividend CAGR of +5.22%

Using MET CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

MET (DRIP)MET - No DRIP
Current Price$95.31$95.31
Start Shares104.92104.92
Start Value$10,000$10,000
  
After 10 years:
Final Share Count129.27104.92
Dividends Payment$0.99$0.99
Annual Dividends$510$414
Yield on cost5.10%4.14%
Share Price$236.07$236.07
Total Dividends$3,559$3,160
Final Value$30,516$27,929

Estimated Future Value + Dividends - MET

NOTE: Above numbers are our estimate based on MET's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

MetLife, Inc. (MET) had its IPO on 2000-04-05, and is trader on NYSE stock exchange.

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

MET website: https://www.metlife.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]